
Sign up to save your podcasts
Or


Happy holidays! 2020 is drawing to a close with hopeful advances in cholesterol control. Dr. Kahn reviews brand new data on a cholesterol drug about to be approved by the FDA. He also discusses the other options when medications are needed. Inclisiran is the latest addition to the choices for achieving safe and low cholesterol on this edition of Heart Doc VIP on Empower Radio.
By Dr. Joel Kahn4.6
469469 ratings
Happy holidays! 2020 is drawing to a close with hopeful advances in cholesterol control. Dr. Kahn reviews brand new data on a cholesterol drug about to be approved by the FDA. He also discusses the other options when medications are needed. Inclisiran is the latest addition to the choices for achieving safe and low cholesterol on this edition of Heart Doc VIP on Empower Radio.

779 Listeners

1,542 Listeners

3,471 Listeners

875 Listeners

716 Listeners

3,415 Listeners

2,638 Listeners

3,470 Listeners

9,194 Listeners

150 Listeners

2,322 Listeners

847 Listeners

300 Listeners

1,246 Listeners

320 Listeners